FDA 483 - Unither Manufacturing LLC. - May 15, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Unither Manufacturing LLC, a sterile and non-sterile drug manufacturer in Rochester, NY, revealed significant deficiencies across multiple quality system areas. The observations highlight inadequate controls for preventing microbiological contamination, insufficient laboratory testing, and failures in data integrity and quality control unit procedures. These issues indicate a systemic lack of adherence to cGMP requirements, posing potential risks to drug product quality and patient safety.
ID · 4ad3e88f-c1be-454d-83a7-000286a282a1